Atrial Fibrillation in Physically Active Individuals: Effects of Pharmacological and Interventional Management on Athletic Quality of Life
DOI:
https://doi.org/10.12775/QS.2026.54.70407Keywords
atrial fibrillation, management, athlete, quality of lifeAbstract
Introduction: Atrial fibrillation (AF) is a common arrythmia in physically active individuals, particularly enduranse arhletes, raising important considerations regarding the cardiovascular effects of long-term high-intensity exercice. This review explores the correlation between AF and high-intensity training, focusing on how medical and interventional therapies impact athletic performance and quality of life. Aim of work: The aimara of this work is to review the current literature regardinf pharmacological and interventional management strategies for atrial fibrillation (AF) in athlestes, with particular empasis on their impactada on exercise capacity and sport-specific quality of life. Futhermore, the review aims to highlight gasps in studies and propose dirrections for future research and therapeutic innovation in the management of AF amonh physically active individuals. Material and Methods: The review was based on an analysis of articles published up to 2025 in the PubMed database, Google Scholar, and recent guidelines. The keywords we used included: atrial fibrillation, management, athlete, quality of life. Results: AF in athletes is often paroxysmall and asymptomatic, complicating diagnosis. Rate and rhythm control medications are frequently limited by negative effects on exercise capacity. Catheter abaltion, especially pulmonary vein isolaton, demonstrates superior rhythm control and allows atheltes to return to peak performance. Anticoagulation, while neccessary in some cases, presents bleeding risks in contact sports, requiring individualized approaches. Conclusions: Management of AF in atheltes must balance arrhythmia control with performance presevation. Catheter ablation offers the most consistent improvements in athletic qualty of life, whereas pharmacologic therapy is often restrictive. Tailored tretment strategies and futher athlete-specifc research are essential for optimizing care in this unique population.
References
1. Pelliccia A, Sharma S, Gati S, et al. 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease: The Task Force on sports cardiology and exercise in patients with cardiovascular disease of the European Society of Cardiology (ESC). Eur Heart J. 2021;42(1):17-96. doi:10.1093/eurheartj/ehaa605
2. Heidbuchel H, Adami PE, Antz M, et al. Recommendations for participation in leisure-time physical activity and competitive sports in patients with arrhythmias and potentially arrhythmogenic conditions: Part 1: Supraventricular arrhythmias. A position statement of the Section of Sports Cardiology and Exercise from the European Association of Preventive Cardiology (EAPC) and the European Heart Rhythm Association (EHRA), both associations of the European Society of Cardiology. Eur J Prev Cardiol. 2021;28(14):1539-1551. doi:10.1177/2047487320925635
3. Palermi A, Molinari LV, Ricci F, Gallina S, Renda G. Practical guidance for management of atrial fibrillation in sports cardiology. Curr Probl Cardiol. 2025;50(4):102995. doi:10.1016/j.cpcardiol.2025.102995
4. Nesheiwat Z, Goyal A, Jagtap M. Atrial Fibrillation. In: StatPearls. StatPearls Publishing; 2023. Accessed July 24, 2025. http://www.ncbi.nlm.nih.gov/books/NBK526072/
5. Turagam MK, Flaker GC, Velagapudi P, Vadali S, Alpert MA. Atrial Fibrillation In Athletes: Pathophysiology, Clinical Presentation, Evaluation and Management. J Atr Fibrillation. 2015;8(4):1309. doi:10.4022/jafib.1309
6. Pelliccia A, Maron BJ, Di Paolo FM, et al. Prevalence and Clinical Significance of Left Atrial Remodeling in Competitive Athletes. JACC. 2005;46(4):690-696. doi:10.1016/j.jacc.2005.04.052
7. Wernhart S, Halle M. Atrial fibrillation and long-term sports practice: epidemiology and mechanisms. Clin Res Cardiol. 2015;104(5):369-379. doi:10.1007/s00392-014-0805-0
8. Calvo N, Ramos P, Montserrat S, et al. Emerging risk factors and the dose–response relationship between physical activity and lone atrial fibrillation: a prospective case–control study. Europace. 2016;18(1):57-63. doi:10.1093/europace/euv216
9. Sanchis-Gomar F, Perez-Quilis C, Lippi G, et al. Atrial fibrillation in highly trained endurance athletes — Description of a syndrome. Int J Cardiol. 2017;226:11-20. doi:10.1016/j.ijcard.2016.10.047
10. Newman W, Parry-Williams G, Wiles J, et al. Risk of atrial fibrillation in athletes: a systematic review and meta-analysis. Br J Sports Med. 2021;55(21):1233-1238. doi:10.1136/bjsports-2021-103994
11. Lampert R, Chung EH, Ackerman MJ, et al. 2024 HRS expert consensus statement on arrhythmias in the athlete: Evaluation, treatment, and return to play. Heart Rhythm. 2024;21(10):e151-e252. doi:10.1016/j.hrthm.2024.05.018
12. Khan AK, Lee HJ, Hills MT, et al. Impact of atrial fibrillation and atrial fibrillation therapies on sports performance in athletes. Heart Rhythm. 2024;0(0). doi:10.1016/j.hrthm.2024.11.020
13. Furlanello F, Lupo P, Pittalis M, et al. Radiofrequency Catheter Ablation of Atrial Fibrillation in Athletes Referred for Disabling Symptoms Preventing Usual Training Schedule and Sport Competition. J Cardiovasc Electrophysiol. 2008;19(5):457-462. doi:10.1111/j.1540-8167.2007.01077.x
14. Mujović NM, Marinković MM, Nedeljković I, et al. Improvement of Maximal Exercise Performance After Catheter‐Ablation of Atrial Fibrillation and Its Prognostic Significance for Long‐Term Rhythm Outcome. J Am Heart Assoc Cardiovasc Cerebrovasc Dis. 2021;10(3):e017445. doi:10.1161/JAHA.120.017445
15. Van Gelder IC, Rienstra M, Bunting KV, et al. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): Developed by the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC), with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Endorsed by the European Stroke Organisation (ESO). Eur Heart J. 2024;45(36):3314-3414. doi:10.1093/eurheartj/ehae176
16. Certo Pereira J, Lima MR, Moscoso Costa F, et al. Stroke in Athletes with Atrial Fibrillation: A Narrative Review. Diagnostics. 2024;15(1):9. doi:10.3390/diagnostics15010009
17. Abdulla J, Nielsen JR. Is the risk of atrial fibrillation higher in athletes than in the general population? A systematic review and meta-analysis. EP Eur. 2009;11(9):1156-1159. doi:10.1093/europace/eup197
18. Elliott AD, Middeldorp ME, Van Gelder IC, Albert CM, Sanders P. Epidemiology and modifiable risk factors for atrial fibrillation. Nat Rev Cardiol. 2023;20(6):404-417. doi:10.1038/s41569-022-00820-8
19. Ayinde H, Schweizer ML, Crabb V, Ayinde A, Abugroun A, Hopson J. Age modifies the risk of atrial fibrillation among athletes: A systematic literature review and meta-analysis. Int J Cardiol Heart Vasc. 2018;18:25-29. doi:10.1016/j.ijcha.2018.01.002
20. Wilhelm M. Atrial fibrillation in endurance athletes. Eur J Prev Cardiol. 2014;21(8):1040-1048. doi:10.1177/2047487313476414
21. Odening KE, Deiß S, Dilling-Boer D, et al. Mechanisms of sex differences in atrial fibrillation: role of hormones and differences in electrophysiology, structure, function, and remodelling. EP Eur. 2019;21(3):366-376. doi:10.1093/europace/euy215
22. Molina L, Mont L, Marrugat J, et al. Long-term endurance sport practice increases the incidence of lone atrial fibrillation in men: a follow-up study. EP Eur. 2008;10(5):618-623. doi:10.1093/europace/eun071
23. Baldesberger S, Bauersfeld U, Candinas R, et al. Sinus node disease and arrhythmias in the long-term follow-up of former professional cyclists. Eur Heart J. 2008;29(1):71-78. doi:10.1093/eurheartj/ehm555
24. Li S, Zhang Z, Scherlag BJ, Po SS. Atrial Fibrillation in Athletes - The Story Behind The Running Hearts. J Atr Fibrillation. 2010;2(5):231. doi:10.4022/jafib.231
25. Petek BJ, Hayes DM, Wasfy MM. Right Heart Resilience and Atrial Fibrillation Risk in Long-Term Endurance Athletes. J Am Soc Echocardiogr Off Publ Am Soc Echocardiogr. 2022;35(12):1269-1272. doi:10.1016/j.echo.2022.09.019
26. Scridon A. Autonomic imbalance and atrial ectopic activity—a pathophysiological and clinical view. Front Physiol. 2022;13. doi:10.3389/fphys.2022.1058427
27. Al Ghamdi B, Hassan W. Atrial Remodeling And Atrial Fibrillation: Mechanistic Interactions And Clinical Implications. J Atr Fibrillation. 2009;2(1):125. doi:10.4022/jafib.125
28. Neilan TG, Januzzi JL, Lee-Lewandrowski E, et al. Myocardial injury and ventricular dysfunction related to training levels among nonelite participants in the Boston marathon. Circulation. 2006;114(22):2325-2333. doi:10.1161/CIRCULATIONAHA.106.647461
29. Myrstad M, Berge T, Ihle-Hansen H, et al. Stroke in endurance athletes with atrial fibrillation. Eur J Prev Cardiol. 2020;27(19):2123-2125. doi:10.1177/2047487319866273
30. Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373-498. doi:10.1093/eurheartj/ehaa612
31. Stühlinger M, Hintringer F, Berger T. [Palpitations in competitive athletes. Risks from premature beats, nonsustained tachycardia and preexcitation]. Herz. 2009;34(4):315-322. doi:10.1007/s00059-009-3240-7
32. Gajda R, Biernacka EK, Drygas W. Are heart rate monitors valuable tools for diagnosing arrhythmias in endurance athletes? Scand J Med Sci Sports. 2018;28(2):496-516. doi:10.1111/sms.12917
33. Chan P, Wong C, Poh YC, et al. Diagnostic Performance of a Smartphone‐Based Photoplethysmographic Application for Atrial Fibrillation Screening in a Primary Care Setting. J Am Heart Assoc Cardiovasc Cerebrovasc Dis. 2016;5(7):e003428. doi:10.1161/JAHA.116.003428
34. Tison GH, Sanchez JM, Ballinger B, et al. Passive Detection of Atrial Fibrillation Using a Commercially Available Smartwatch. JAMA Cardiol. 2018;3(5):409-416. doi:10.1001/jamacardio.2018.0136
35. Drezner JA, Sharma S, Baggish A, et al. International criteria for electrocardiographic interpretation in athletes: Consensus statement. Br J Sports Med. 2017;51(9):704-731. doi:10.1136/bjsports-2016-097331
36. Lampert R, Chung EH, Ackerman MJ, et al. 2024 HRS expert consensus statement on arrhythmias in the athlete: Evaluation, treatment, and return to play. Heart Rhythm. 2024;21(10):e151-e252. doi:10.1016/j.hrthm.2024.05.018
37. Steffel J, Collins R, Antz M, et al. 2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation. EP Eur. 2021;23(10):1612-1676. doi:10.1093/europace/euab065
38. Minardi S, Sciarra L, Robles AG, et al. Thromboembolic prevention in athletes: management of anticoagulation in sports players affected by atrial fibrillation. Front Pharmacol. 2024;15:1384213. doi:10.3389/fphar.2024.1384213
39. Moll S, Berkowitz JN, Miars CW. Elite athletes and anticoagulant therapy: an intermittent dosing strategy. Hematol Am Soc Hematol Educ Program. 2018;2018(1):412-417. doi:10.1182/asheducation-2018.1.412
40. Calvo N, Mont L, Tamborero D, et al. Efficacy of circumferential pulmonary vein ablation of atrial fibrillation in endurance athletes. Europace. 2010;12(1):30-36. doi:10.1093/europace/eup320
41. Koopman P, Nuyens D, Garweg C, et al. Efficacy of radiofrequency catheter ablation in athletes with atrial fibrillation. EP Eur. 2011;13(10):1386-1393. doi:10.1093/europace/eur142
42. Tzeis S, Gerstenfeld EP, Kalman J, et al. 2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation. Europace. 2024;26(4):euae043. doi:10.1093/europace/euae043
43. Liu MB, Lee JZ, Klooster L, Buckner Petty SA, Scott LR. Influence of endurance sports on atrial fibrillation ablation outcomes. J Arrhythmia. 2022;38(5):694-709. doi:10.1002/joa3.12746
44. Yu Y, Jiang Q. Surgical Methods and Devices for Atrial Fibrillation. Rev Cardiovasc Med. 2025;26(4):26841. doi:10.31083/RCM26841
45. Trohman RG. Narrative Review: Surgical and Hybrid Management of Atrial Fibrillation. Cardiol Ther. 2024;13(3):493-528. doi:10.1007/s40119-024-00377-2
46. Li L, Xie B. Pulsed field ablation for atrial fibrillation: a comprehensive bibliometric analysis of research trends and emerging Frontiers. Front Cardiovasc Med. 2025;12. doi:10.3389/fcvm.2025.1513942
47. Kontogiannis C, Petrone A, Akhtar Z, et al. Ultra-low temperature cryoablation vs. radiofrequency ablation for the management of atrial fibrillation: long term outcomes. EP Eur. 2025;27(Supplement_1):euaf085.200. doi:10.1093/europace/euaf085.200
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Julia Kępska, Oliwia Sędziak, Magdalena Jabłonowska, Karolina Szpilczyńska, Julia Gąsiorowska, Monika Cieślak, Marta Miklejewska, Katarzyna Kleszczewska, Laura Gawlik, Anna Krasowska
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 25
Number of citations: 0
